TrialNature cancer2026

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

Ya-Lan Tao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.